Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Fate Therapeutics (FATE) Q4 2025 Earnings
FATE
13
Nov
Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.44
-0.38
-0.33
-0.27
Details
Expected EPS
-0.292142
Actual EPS
-0.27
Surprise EPS
0.02
Surprise Percent
+7.58%
Description
Fate Therapeutics (FATE) has reported earnings of -0.27 per share for Q4 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login